NIH Chief Collins Supports More Aggressive DTC Genetic Testing Oversight
This article was originally published in The Gray Sheet
Executive Summary
National Institutes of Health Director Francis Collins, an influential supporter of genomic research and applications, says he has been urging FDA to take a "more aggressive role" in overseeing direct-to-consumer genetic tests
You may also be interested in...
FDA To Regulate Direct-To-Consumer Genetic Tests
Citing the need to prove that direct-to-consumer genetic assays are analytically and clinically accurate, CDRH sent letters to five genetic testing firms June 10 requesting pre-market submissions for the companies' already-marketed services
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”